An official of the Korean Ministry of Knowledge Economy, who asked not to be named, said, "By December, Sanofi-Aventis plans to select a local investment partner that best meets its R&D requirements."
The prososed investment, whose volume has not been vealed, is expected to be in areas related to research on the cardiovascular and central nervous system.<헬스코리아뉴스>
저작권자 © 헬스코리아뉴스 무단전재 및 재배포 금지